ArticleJournal of biochemical and molecular toxicology2025
Paracetamol Induces Apoptosis, Reduces Colony Formation, and Increases PTPRO Gene Expression in Human Embryonic Kidney HEK 293 Cells.
Article in Journal of biochemical and molecular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Paracetamol and Metformin Reduce NK-Cell Susceptibility in MCF-7 Breast Cancer Cells in Association with Enrichment of Immune-Evasive CD44International journal of molecular sciences · 2026Article
- A comprehensive review on bacterial endophytic secondary metabolites: a road map from crude extract to lead molecule production.Frontiers in pharmacology · 2026Review
- Can Acetaminophen be Used as a Chemotherapeutic Agent in the Kidney?Journal of biochemical and molecular toxicology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paracetamol (acetaminophen) is a widely used analgesic and antipyretic drug. Although many studies are available showing that paracetamol causes hepatic damage, few studies exist on renal damage. Protein tyrosine phosphatase receptor type O (PTPRO) protein has tyrosine phosphatase activity and plays a role in the regulation of the renal glomerular pressure/filtration rate relationship in podocyte structure. The PTPRO gene also exhibits characteristics of a candidate tumor suppressor gene. In this study, apoptosis, cell cycle, colony formation, and PTPRO gene expression of the human embryonic kidney (HEK 293) cells were assessed by treating with paracetamol at different concentrations for 24 and 26 h in at least three independent trials. Paracetamol induced dose-dependent apoptosis at all concentrations (5, 10, 15, 20, and 30 mM) for both 24 and 26 h (p < 0.05-p < 0.001). Paracetamol decreased dose-dependent colony-forming potential of cells at 10.000 cells seeding in HEK 293 cells at all concentrations (5, 10, 15, 20, and 30 mM) (p < 0.05-p < 0.001). In HEK 293 cells, paracetamol also increased cell population in the G0-G1 phase at low 5 mM concentration for 26 h (p < 0.05), while reducing cell population in the G2-M phase of the cell cycle at 10 mM and increasing at 30 mM concentration for 24 h (p < 0.05 and p < 0.05, respectively). Paracetamol at high concentration (30 mM) increased PTPRO gene expression in HEK 293 cells for both 24 and 26 h (p < 0.05). In conclusion, our results may indicate that paracetamol may suppress the development of renal cancer by inducing apoptosis and reducing colony formation in a dose-dependent manner, and upregulating PTPRO gene expression in HEK 293 cells at high concentration, in addition to its renal-damaging role. Further research is necessary to determine the potential role or detrimental effects of paracetamol on the development of renal cancer, as the mechanism underlying its effects on renal damage and cancer formation remains unclear.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.